What is Bolt Biotherapeutics, Inc. Common Stock's Market Cap?

Bolt Biotherapeutics, Inc. Common Stock's Market Cap is $7.5M, based on as-reported figures from SEC (XBRL) filings.

What is Bolt Biotherapeutics, Inc. Common Stock's Enterprise Value?

Bolt Biotherapeutics, Inc. Common Stock's Enterprise Value is -$10.1M, based on as-reported figures from SEC (XBRL) filings.

What is Bolt Biotherapeutics, Inc. Common Stock's Price / Sales?

Bolt Biotherapeutics, Inc. Common Stock's Price / Sales is 1.6×, based on as-reported figures from SEC (XBRL) filings.

What is Bolt Biotherapeutics, Inc. Common Stock's EV / Revenue?

Bolt Biotherapeutics, Inc. Common Stock's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Bolt Biotherapeutics, Inc. Common Stock's EV / EBITDA?

Bolt Biotherapeutics, Inc. Common Stock's EV / EBITDA is 0.3×, based on as-reported figures from SEC (XBRL) filings.

What is Bolt Biotherapeutics, Inc. Common Stock's Revenue (TTM)?

Bolt Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $4.7M, based on as-reported figures from SEC (XBRL) filings.

What is Bolt Biotherapeutics, Inc. Common Stock's Net Income (TTM)?

Bolt Biotherapeutics, Inc. Common Stock's Net Income (TTM) is -$28.7M, based on as-reported figures from SEC (XBRL) filings.

What is Bolt Biotherapeutics, Inc. Common Stock's EBITDA?

Bolt Biotherapeutics, Inc. Common Stock's EBITDA is -$29.8M, based on as-reported figures from SEC (XBRL) filings.

What is Bolt Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Bolt Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is -14.92, based on as-reported figures from SEC (XBRL) filings.

What is Bolt Biotherapeutics, Inc. Common Stock's EBITDA Margin?

Bolt Biotherapeutics, Inc. Common Stock's EBITDA Margin is -635.0%, based on as-reported figures from SEC (XBRL) filings.

Bolt Biotherapeutics, Inc. Common Stock (BOLT) Financial Statements

Bolt Biotherapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00N8MY5W8

XNAS · usd

3.88▲ 0.02 (0.52%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close3.86

Day's Range3.53 – 3.94

52-Week Range3.13 – 7.20

Volume7,347

Avg Volume21.5K

Share Statistics

Shares Outstanding

Employees23

ExchangeXNAS

Listed2021-02-05

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Bolt Biotherapeutics, Inc. Common Stock (BOLT)

What is Bolt Biotherapeutics, Inc. Common Stock's Market Cap?: Bolt Biotherapeutics, Inc. Common Stock's Market Cap is $7.5M, based on as-reported figures from SEC (XBRL) filings.
What is Bolt Biotherapeutics, Inc. Common Stock's Enterprise Value?: Bolt Biotherapeutics, Inc. Common Stock's Enterprise Value is -$10.1M, based on as-reported figures from SEC (XBRL) filings.
What is Bolt Biotherapeutics, Inc. Common Stock's Price / Sales?: Bolt Biotherapeutics, Inc. Common Stock's Price / Sales is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is Bolt Biotherapeutics, Inc. Common Stock's EV / Revenue?: Bolt Biotherapeutics, Inc. Common Stock's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Bolt Biotherapeutics, Inc. Common Stock's EV / EBITDA?: Bolt Biotherapeutics, Inc. Common Stock's EV / EBITDA is 0.3×, based on as-reported figures from SEC (XBRL) filings.
What is Bolt Biotherapeutics, Inc. Common Stock's Revenue (TTM)?: Bolt Biotherapeutics, Inc. Common Stock's Revenue (TTM) is $4.7M, based on as-reported figures from SEC (XBRL) filings.
What is Bolt Biotherapeutics, Inc. Common Stock's Net Income (TTM)?: Bolt Biotherapeutics, Inc. Common Stock's Net Income (TTM) is -$28.7M, based on as-reported figures from SEC (XBRL) filings.
What is Bolt Biotherapeutics, Inc. Common Stock's EBITDA?: Bolt Biotherapeutics, Inc. Common Stock's EBITDA is -$29.8M, based on as-reported figures from SEC (XBRL) filings.
What is Bolt Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Bolt Biotherapeutics, Inc. Common Stock's Diluted EPS (TTM) is -14.92, based on as-reported figures from SEC (XBRL) filings.
What is Bolt Biotherapeutics, Inc. Common Stock's EBITDA Margin?: Bolt Biotherapeutics, Inc. Common Stock's EBITDA Margin is -635.0%, based on as-reported figures from SEC (XBRL) filings.